GlassScriptPhysician profile
Ulysses Hsu
NPI 1467977033
$1,774.28
in general payments reported to CMS, 2019-2025
6 companies · $646 in 2025
The $646 reported for 2025 was more than what 84% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $25.00 · 2023: $42.84 · 2024: $915 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986 · Consulting Fee: $315 · Travel and Lodging: $222 · Education: $70.00 · Gift: $10.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.73 |
| Consulting Fee | $315.00 |
| Travel and Lodging | $222.29 |
| Education | $70.00 |
| Gift | $10.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,375.71 | 2021-2025 | Invisalign, Itero, Maob |
| Envista Holdings Corporation | $241.20 | 2024-2025 | Spark |
| Lightforce Orthodontics, INC. | $91.08 | 2024-2025 | |
| American Orthodontics Corporation | $48.55 | 2024-2025 | Master Series, Empower-Metal, LP and Ifit Tubes |
| Solventum Corporation | $16.19 | 2025 | |
| USA Angelalign Technology Corp | $1.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ulysses Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.